Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Bam Regimen Followed By High-Dose Therapy and Autologous Stem Cell Transplantation As First-Line Treatment Of Primary Central Nervous System Lymphoma: A Multicenter Study From Spanish Group GEL-TAMO

Blood (2013) 122 (21): 4349.

https://doi.org/10.1182/blood.V122.21.4349.4349

Published: 2013

Journal Articles

Safety of Intrathecal Liposomal Cytarabine (Depocyte®) Injection Given Prophylactically in Patients with High-Risk Diffuse Large B-Cell Lymphoma: A Report of 22 Patients in Spain.

Miguel A. Canales, A. Salar, J.A. Diaz, J.J. Ferreiro, S. Ferrer, A. Llorente, D. Caballero, J.A. Garcia-Marco, L. Palomera, J.J. Sanchez-Blanco, E. Gonzalez-Barca

Blood (2007) 110 (11): 4459.

https://doi.org/10.1182/blood.V110.11.4459.4459

Published: 2007

Journal Articles

Identification of Neoplastic Infiltration of the Cerebrospinal Fluid (CSF) in Patients with Aggressive B-Cell Non-Hodgkin’s Lymphoma (B-NHL) without Clinical Evidence of Leptomeningeal Disease: A Comparative Analysis of the Utility of Flow Cytometry (FCM) Versus Conventional Cytology (CC).

A. Orfao, MD, PhD, S. Quijano, MSc, A. Lopez, BSc, G. Deben, MD, A. Salar, MD, C. Poderos, MD, J.M. Sancho, MD, C. Vallejo, MD, J. Arias, MD, J.A. Garcia, MD, F. Capote, MD, M. Morado, MD, C. Nicolas, MD, J. Briones, MD, S. Fernandez, MD, A. Carmona, MD, L. Vazquez, MD, J.F. San Miguel, MD, PhD

Blood (2006) 108 (11): 4605.

https://doi.org/10.1182/blood.V108.11.4605.4605

Published: 2006

Journal Articles

A Prospective, Observational Study of the Effectiveness and Safety of a Weekly Fixed Dose of Darbepoetin alfa with Current Practice Iron Management for the Treatment of Chemotherapy-Induced Anemia (CIA): A Subanalysis in Patients (pts) with Lymphoproliferative Malignancies (LPM).

A. Alegre, A. Salar, I. Roig, J.C. Bermejo, A. Palacios, R. de Paz, R. Arranz, A. Fernández, R. Calzada, P. Iturralde, On Behalf of the AMG-DAR-2002-01 Study Group

Blood (2005) 106 (11): 3715.

https://doi.org/10.1182/blood.V106.11.3715.3715

Published: 2005

Journal Articles

Characterization of New Aberrations in 25 Splenic Marginal Zone B-Cell Lymphomas (SMZBCL) Using Spectral Karyotyping Technique (SKY).

C. Baro, PhD, L. Astier, PhD, M. Salido, PhD, B. Espinet, PhD, A. Domingo, MD, I. Granada, PhD, D. Costa, PhD, J.M. Hernandez, MD, L. Florensa, MD, A. Salar, MD, S. Serrano, MD, F. Sole, PhD

Blood (2005) 106 (11): 4658.

https://doi.org/10.1182/blood.V106.11.4658.4658

Published: 2005

Journal Articles

First-Line Treatment with R-Chop/21 for Patients with Disseminated Diffuse Large B-Cell Lymphoma (DLCL). Results of a Prospective Series of 128 Patients.

E. Gonzalez-Barca, PhD, E. Domingo-Domenech, MD, J. M. Ribera, PhD, J. Briones, PhD, A. Salar, PhD, L. Gallur, MD, C. Estany, MD, L. Escoda, MD, S. Gardella, MD, J. A. Hernandez, MD, J. Rodriguez, MD, E. Ramila, MD, O. Ramon, MD, M. Garcia-Pinto, MD, I. Español, PhD, P. Vivancos, MD, A. Asensio, MD, M. Encuentra, A. Fernandez de Sevilla, PhD

Blood (2004) 104 (11): 4573.

https://doi.org/10.1182/blood.V104.11.4573.4573

Published: 2004

Journal Articles

First-Line Treatment with Rituximab Improves Survival of Patients with Post-Transplant Lymphoproliferative Disease (PTLD).

E. Gonzalez-Barca, PhD, E. Domingo-Domenech, MD, J. Gomez-Codina, MD, F. Capote, MD, E. Flores, MD, J. Briones, PhD, A. Salar, PhD, C. Panizo, MD, C. Montalban, PhD, J. M. Ribera, PhD, D. Caballero, PhD, A. Muñoz, MD, L. Gallur, MD, M.A. Canales, MD, P. Fernandez, MD, M. Encuentra, A. Fernandez de Sevilla, PhD

Blood (2004) 104 (11): 1406.

https://doi.org/10.1182/blood.V104.11.1406.1406

Published: 2004

NARROW

Bam Regimen Followed By High-Dose Therapy and Autologous Stem Cell Transplantation As First-Line Treatment Of Primary Central Nervous System Lymphoma: A Multicenter Study From Spanish Group GEL-TAMO

Safety of Intrathecal Liposomal Cytarabine (Depocyte®) Injection Given Prophylactically in Patients with High-Risk Diffuse Large B-Cell Lymphoma: A Report of 22 Patients in Spain.

Identification of Neoplastic Infiltration of the Cerebrospinal Fluid (CSF) in Patients with Aggressive B-Cell Non-Hodgkin’s Lymphoma (B-NHL) without Clinical Evidence of Leptomeningeal Disease: A Comparative Analysis of the Utility of Flow Cytometry (FCM) Versus Conventional Cytology (CC).

A Prospective, Observational Study of the Effectiveness and Safety of a Weekly Fixed Dose of Darbepoetin alfa with Current Practice Iron Management for the Treatment of Chemotherapy-Induced Anemia (CIA): A Subanalysis in Patients (pts) with Lymphoproliferative Malignancies (LPM).

Characterization of New Aberrations in 25 Splenic Marginal Zone B-Cell Lymphomas (SMZBCL) Using Spectral Karyotyping Technique (SKY).

First-Line Treatment with R-Chop/21 for Patients with Disseminated Diffuse Large B-Cell Lymphoma (DLCL). Results of a Prospective Series of 128 Patients.

First-Line Treatment with Rituximab Improves Survival of Patients with Post-Transplant Lymphoproliferative Disease (PTLD).

Email alerts

ASH Publications

American Society of Hematology

Bam Regimen Followed By High-Dose Therapy and Autologous Stem Cell Transplantation As First-Line Treatment Of Primary Central Nervous System Lymphoma: A Multicenter Study From Spanish Group GEL-TAMO

Safety of Intrathecal Liposomal Cytarabine (Depocyte®) Injection Given Prophylactically in Patients with High-Risk Diffuse Large B-Cell Lymphoma: A Report of 22 Patients in Spain.

Identification of Neoplastic Infiltration of the Cerebrospinal Fluid (CSF) in Patients with Aggressive B-Cell Non-Hodgkin’s Lymphoma (B-NHL) without Clinical Evidence of Leptomeningeal Disease: A Comparative Analysis of the Utility of Flow Cytometry (FCM) Versus Conventional Cytology (CC).

A Prospective, Observational Study of the Effectiveness and Safety of a Weekly Fixed Dose of Darbepoetin alfa with Current Practice Iron Management for the Treatment of Chemotherapy-Induced Anemia (CIA): A Subanalysis in Patients (pts) with Lymphoproliferative Malignancies (LPM).

Characterization of New Aberrations in 25 Splenic Marginal Zone B-Cell Lymphomas (SMZBCL) Using Spectral Karyotyping Technique (SKY).

First-Line Treatment with R-Chop/21 for Patients with Disseminated Diffuse Large B-Cell Lymphoma (DLCL). Results of a Prospective Series of 128 Patients.

First-Line Treatment with Rituximab Improves Survival of Patients with Post-Transplant Lymphoproliferative Disease (PTLD).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only